Incentives for orphan drug research and development in the United States

<p>Abstract</p> <p>Background</p> <p>The Orphan Drug Act (1983) established several incentives to encourage the development of orphan drugs (ODs) to treat rare diseases and conditions. This study analyzed the characteristics of OD designations, approvals, sponsors, and...

Full description

Bibliographic Details
Main Authors: Rodriguez-Monguio Rosa, Seoane-Vazquez Enrique, Szeinbach Sheryl L, Visaria Jay
Format: Article
Language:English
Published: BMC 2008-12-01
Series:Orphanet Journal of Rare Diseases
Online Access:http://www.ojrd.com/content/3/1/33